These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 26575409

  • 1. Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-α inhibitor treatment in rheumatoid arthritis: a prospective cohort study.
    Inanc N, Ozen G, Direskeneli H.
    Clin Exp Rheumatol; 2016; 34(1):156. PubMed ID: 26575409
    [No Abstract] [Full Text] [Related]

  • 2. Anti-TNF scintigraphy to assess TNF-α-associated joint inflammation in rheumatoid arthritis and osteoarthritis.
    Hermann J, Lipp RW, Dunzinger A, Spreizer C, Schaffler G, Kvaternik H, Ofner P, Graninger W.
    Clin Exp Rheumatol; 2014; 32(4):614. PubMed ID: 24959905
    [No Abstract] [Full Text] [Related]

  • 3. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis.
    Kamishima T, Kato M, Atsumi T, Koike T, Onodera Y, Terae S.
    Clin Exp Rheumatol; 2013; 31(1):154. PubMed ID: 23190694
    [No Abstract] [Full Text] [Related]

  • 4. Ultrasound-detected joint inflammation and B cell count: related variables for rituximab-treated RA patients?
    Valor L, Martínez-Estupiñán L, Janta I, Nieto JC, Ovalles-Bonilla JG, González-Fernández C, Del Rio T, Hernández-Flórez D, Monteagudo I, López-Longo FJ, Naredo E.
    Rheumatol Int; 2016 Jun; 36(6):793-7. PubMed ID: 27072348
    [Abstract] [Full Text] [Related]

  • 5. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
    Janta I, Valor L, De la Torre I, Martínez-Estupiñán L, Nieto JC, Ovalles-Bonilla JG, Martínez-Barrio J, Bello N, Hinojosa M, Montoro M, González CM, López-Longo J, Monteagudo I, Carreño L, Naredo E.
    Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression.
    Naredo E, Collado P, Cruz A, Palop MJ, Cabero F, Richi P, Carmona L, Crespo M.
    Arthritis Rheum; 2007 Feb 15; 57(1):116-24. PubMed ID: 17266071
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.
    Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P.
    Arthritis Rheum; 2007 Dec 15; 57(8):1564-7. PubMed ID: 18050231
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factors influencing concordance between clinical and ultrasound findings in rheumatoid arthritis.
    Le Boedec M, Jousse-Joulin S, Ferlet JF, Marhadour T, Chales G, Grange L, Hacquard-Bouder C, Loeuille D, Sellam J, Albert JD, Bentin J, Chary-Valckenaere I, D'Agostino MA, Etchepare F, Gaudin P, Hudry C, Dougados M, Saraux A.
    J Rheumatol; 2013 Mar 15; 40(3):244-52. PubMed ID: 23322464
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
    Reiche BE, Ohrndorf S, Feist E, Messerschmidt J, Burmester GR, Backhaus M.
    Arthritis Care Res (Hoboken); 2014 Feb 15; 66(2):204-16. PubMed ID: 23925935
    [Abstract] [Full Text] [Related]

  • 17. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
    Filippucci E, Iagnocco A, Salaffi F, Cerioni A, Valesini G, Grassi W.
    Ann Rheum Dis; 2006 Nov 15; 65(11):1433-7. PubMed ID: 16504996
    [Abstract] [Full Text] [Related]

  • 18. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
    Iagnocco A, Finucci A, Ceccarelli F, Perricone C, Iorgoveanu V, Valesini G.
    Rheumatology (Oxford); 2015 Oct 15; 54(10):1890-6. PubMed ID: 26070937
    [Abstract] [Full Text] [Related]

  • 19. A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment.
    Hammer HB, Sveinsson M, Kongtorp AK, Kvien TK.
    Ann Rheum Dis; 2010 Jul 15; 69(7):1349-51. PubMed ID: 20472599
    [Abstract] [Full Text] [Related]

  • 20. Comparison of discrimination and prognostic value of two US Doppler scoring systems in rheumatoid arthritis patients: a prospective cohort study.
    Ellegaard K, Terslev L, Christensen R, Szkudlarek M, Schmidt WA, Jensen PS, Bliddal H, Torp-Pedersen S.
    Clin Exp Rheumatol; 2014 Jul 15; 32(4):495-500. PubMed ID: 24960526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.